酶ChE,胆性疗法和分子对接:重要的考虑和未来的前景
1Department of Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
胆酶 (ChE) 酶对于胆和非胆功能都至关重要. 了解ChE基因多态是开发各种疾病新疗法策略的关键.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 胆酶 (ChE) 酶对于突触神经传递之外的许多生理过程至关重要.
- 它们在血液形成,骨发育和粉样纤维形成等不同领域充当信号受体.
- 在生殖细胞中发现了ChE,这表明它在更广泛的生物功能中发挥了作用.
研究的目的:
- 审查胆酶 (ChE) 酶的多方面的作用.
- 探索ChE基因多态性对疾病和药物反应的影响.
- 突出ChE抑制剂作为治疗点的潜力.
主要方法:
- 使用NCBI和谷歌学者进行了全面的文献审查.
- 包括标准侧重于基因组组织,基因转录,酶结构,功能和多态性.
- 与疾病和药物反应相关的酶活性分析.
主要成果:
- 酶具有重要的非胆性信号传递作用.
- 在ChE基因中的多态性与各种疾病有关,包括癌症,神经退行性和心血管疾病.
- 基因变异会影响个体对药物的反应.
结论:
- 胆酶 (ChE) 酶是具有多种生物功能的关键信号分子.
- E基因多态性为新的治疗标和个性化医学提供了机会.
- 对ChE抑制剂的进一步研究可以推进疾病治疗策略.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
